4//SEC Filing
Bell Graeme 4
Accession 0001209191-18-005804
CIK 0001652130other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 3:31 PM ET
Size
5.4 KB
Accession
0001209191-18-005804
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-25+25,000→ 25,000 totalExercise: $22.78Exp: 2028-01-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 25, 2018 with respect to 25,000 shares of Common Stock, with 25% vesting on January 25, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001643757
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 3:31 PM ET
- Size
- 5.4 KB